Haematology is the study of blood and bone marrow disorders and includes the diagnosis, treatment, prognosis and management of people with cancers such as leukaemia, lymphoma and multiple myeloma. The clinicians and nurses are actively involved in research directed at improving patient care, while the department also supports dedicated laboratory and clinical trials teams. There are generally 20-30 trials available to patients, with many administered by the Australasian Leukaemia and Lymphoma Group (ALLG). In addition, patients can choose to donate tissue samples to the ALLG tissue bank to help further research into blood disorders. The Hunter Haematology Unit is also a contributing member of the Centre for International Blood and Marrow Transplant Research (CIBMTR) based in Wisconsin, USA.
The Haematology Unit is also home to the Hunter Haematology Research Laboratory which conducts lab-based studies into haematological cancers and disorders of coagulation, with a primary interest in circulating microparticles. The laboratory is linked to the University of Newcastle and the Hunter Medical Research Institute (HMRI) and offers tuition and scholarships to encourage students to enter this area of research. The group maintains strong collaborations with researchers both nationally (School of Human Life Sciences, University of Tasmania) and locally with the departments of Neurology, Endocrinology (John Hunter Hospital), Molecular and Cytogenetics (Hunter New England Health), Toxicology (Calvary Mater Newcastle), Medical Oncology (Calvary Mater Newcastle), School of Biomedical Sciences and Pharmacy (University of Newcastle) and the Priority Research Centre for Health Behaviour, School of Medicine and Public Health (University of Newcastle).